| ESP | early systolic paradox; echo spacing; effective sensory projection; effective systolic pressure; end... |
|---|---|
| PS | pacemaker syndrome; paired stimulation; paradoxical sleep; paraspinal; parasympathetic; Parkinson sy... |
| TES | thymic epithelial supernatant; toxic epidemic syndrome; transcutaneous electrical stimulation; trans... |
| PIE | 1) Post-Infectious Encephalomyelitis 2) Pulmonary Interstitial Emphysema;... |
| CFU-EOS, | CFUEOS colony-forming unit, eosinophil |
| EO | Eosinophil |
|---|---|
| ECP | Eosinophil Cationic Protein |
| ECA | Eosinophil chemotactic activity |
| ECF | Eosinophil chemotactic factor |
| EDN | Eosinophil derived neurotoxin |
| absolute eosinophil count | <haematology, investigation> A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre). (27 Sep 1997) |
|---|---|
| chemotactic factors, eosinophil | Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ecf-a, released mainly by mast cells. (12 Dec 1998) |
| eosinophil | Polymorphonuclear leucocyte (granulocyte) of the myeloid series, of which the granules stain red with eosin. Phagocytic, particularly associated with helminth infections and with hypersensitivity. (18 Nov 1997) |
| eosinophil adenoma | <endocrinology, oncology, tumour> A benign tumour, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumours may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhoea. (25 Jun 1999) |
| eosinophil cationic protein | <protein> Arginine rich protein (21 kD) in granules of eosinophils, that damages schistosomula in vitro. Not the same as the MBP (major basic protein) of the granules. (18 Nov 1997) |
| eosinophil chemotactic factor of anaphylaxis | A peptide (MW 500 to 600) that is chemotactic for eosinophilic leukocytes and is released from disrupted mast cells. (05 Mar 2000) |
| eosinophil chemotactic peptide | <protein> Tetrapeptides (of which two are identified: VGSE and AGSE) released by mast cells and that are said to both attract and activate eosinophils. (18 Nov 1997) |
| eosinophil count | A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement, also called the absolute eosinophil count, is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre). (27 Sep 1997) |
| eosinophil granule | A granule that stains with eosin. (05 Mar 2000) |
| eosinophil peroxidase | <enzyme> Peroxidase from eosinophil granules distinct from myeloperoxidase; claimed to enhance destruction of fungi, bacteria, schistosomula, toxoplasma, trypanosoma, mast cells, tumour cells in presence of exogenous h2o2 and halide Registry number: EC 1.11.1.- (26 Jun 1999) |
| ACTH stimulation test | A test for adrenal cortical function; ACTH administered by continuous intravenous infusion, or intramuscularly, evokes an increase in plasma cortisol in normal persons; in adrenal cortical insufficiency, the expected increase in plasma cortisol is limited or nonexistent. (05 Mar 2000) |
| Ganzfeld stimulation | Illumination of the entire retina in the electroretinogram. Origin: Ger. Ganzfeld, whole field (05 Mar 2000) |
| percutaneous stimulation | Electrical stimulation of the peripheral nerves or spinal cord by the application of electrodes to the skin. (05 Mar 2000) |
| growth hormone stimulation test | <investigation> A test which measures the level of human growth hormone in response to the administration of the amino acid arginine. This test measures the ability of the pituitary gland to secrete growth hormone. Normal values in children are: 48 ng/ml. Normal values in men are 10 ng/ml. Normal values in women are 15 ng/ml. This test is used to evaluate infants with growth retardation. It may also be part of an evaluation for a pituitary tumour. Failure of arginine to raise growth hormone levels may indicate hypopituitarism or dwarfism. (27 Sep 1997) |
| photic stimulation | The use of a flickering light at various frequencies to influence the pattern of the occipital electroencephalogram and also to activate latent abnormalities. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|